• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于帕金森病的自组装α-突触核蛋白纳米清除剂。

A Self-Assembled α-Synuclein Nanoscavenger for Parkinson's Disease.

机构信息

School of Medicine , Xiamen University , Xiamen 361102 , China.

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine, School of Public Health , Xiamen University , Xiamen 361102 , China.

出版信息

ACS Nano. 2020 Feb 25;14(2):1533-1549. doi: 10.1021/acsnano.9b06453. Epub 2020 Feb 10.

DOI:10.1021/acsnano.9b06453
PMID:32027482
Abstract

Although emerging evidence suggests that the pathogenesis of Parkinson's disease (PD) is closely related to the aggregation of alpha-synuclein (α-syn) in the midbrain, the clearance of α-syn remains an unmet clinical need. Here, we develop a simple and efficient strategy for fabricating the α-syn nanoscavenger for PD a reprecipitation self-assembly procedure. The curcumin analogue-based nanoscavenger (NanoCA) is engineered to be capable of a controlled-release property to stimulate nuclear translocation of the major autophagy regulator, transcription factor EB (TFEB), triggering both autophagy and calcium-dependent exosome secretion for the clearance of α-syn. Pretreatment of NanoCA protects cell lines and primary neurons from MPP-induced neurotoxicity. More importantly, a rapid arousal intranasal delivery system (RA-IDDS) was designed and applied for the brain-targeted delivery of NanoCA, which affords robust neuroprotection against behavioral deficits and promotes clearance of monomer, oligomer, and aggregates of α-syn in the midbrain of an MPTP mouse model of PD. Our findings provide a clinically translatable therapeutic strategy aimed at neuroprotection and disease modification in PD.

摘要

虽然新出现的证据表明帕金森病 (PD) 的发病机制与中脑 α-突触核蛋白 (α-syn) 的聚集密切相关,但 α-syn 的清除仍然是未满足的临床需求。在这里,我们开发了一种制造用于 PD 的 α-syn 纳米清除剂的简单高效策略 - 重沉淀自组装程序。基于姜黄素类似物的纳米清除剂(NanoCA)被设计为能够控制释放特性,以刺激主要自噬调节剂转录因子 EB (TFEB) 的核易位,引发自噬和钙依赖性外体分泌以清除 α-syn。NanoCA 的预处理可保护细胞系和原代神经元免受 MPP 诱导的神经毒性。更重要的是,设计并应用了一种快速唤醒鼻腔给药系统(RA-IDDS)用于 NanoCA 的脑靶向递送,该系统可提供针对 PD 中 MPTP 小鼠模型中行为缺陷的强大神经保护作用,并促进中脑 α-syn 单体、寡聚体和聚集体的清除。我们的研究结果提供了一种具有临床转化潜力的治疗策略,旨在针对 PD 进行神经保护和疾病修饰。

相似文献

1
A Self-Assembled α-Synuclein Nanoscavenger for Parkinson's Disease.一种用于帕金森病的自组装α-突触核蛋白纳米清除剂。
ACS Nano. 2020 Feb 25;14(2):1533-1549. doi: 10.1021/acsnano.9b06453. Epub 2020 Feb 10.
2
Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model.姜黄素提供神经保护并抑制脂多糖诱导的帕金森病模型中的α-突触核蛋白聚集。
Inflammopharmacology. 2018 Apr;26(2):349-360. doi: 10.1007/s10787-017-0402-8. Epub 2017 Oct 12.
3
Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.冬凌草甲素是一种天然生物碱,通过 PKA 介导的 UPS 激活促进转帕金森病模型中α-突触核蛋白的降解。
Phytomedicine. 2021 Jul;87:153578. doi: 10.1016/j.phymed.2021.153578. Epub 2021 Apr 27.
4
AMPK-dependent autophagy activation and alpha-Synuclein clearance: a putative mechanism behind alpha-mangostin's neuroprotection in a rotenone-induced mouse model of Parkinson's disease.AMPK 依赖性自噬激活和 alpha-突触核蛋白清除:芒果苷在鱼藤酮诱导的帕金森病小鼠模型中神经保护作用的潜在机制。
Metab Brain Dis. 2022 Dec;37(8):2853-2870. doi: 10.1007/s11011-022-01087-1. Epub 2022 Sep 30.
5
TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity.TFEB 介导的自噬可挽救中脑多巴胺神经元免受α-突触核蛋白毒性的影响。
Proc Natl Acad Sci U S A. 2013 May 7;110(19):E1817-26. doi: 10.1073/pnas.1305623110. Epub 2013 Apr 22.
6
A Curcumin Derivative Activates TFEB and Protects Against Parkinsonian Neurotoxicity .姜黄素衍生物激活 TFEB 并防止帕金森病神经毒性。
Int J Mol Sci. 2020 Feb 22;21(4):1515. doi: 10.3390/ijms21041515.
7
Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease.自噬依赖性清除 α-突触核蛋白:GM1 神经节苷脂防治帕金森病的新机制。
Acta Pharmacol Sin. 2021 Apr;42(4):518-528. doi: 10.1038/s41401-020-0454-y. Epub 2020 Jul 28.
8
Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.姜黄素在帕金森病诱导性 PC12 细胞模型中可预防 A53T ɑ-突触核蛋白诱导的毒性。
Pharmacol Res. 2011 May;63(5):439-44. doi: 10.1016/j.phrs.2011.01.004. Epub 2011 Jan 12.
9
Beta-asarone protects against MPTP-induced Parkinson's disease via regulating long non-coding RNA MALAT1 and inhibiting α-synuclein protein expression.β-细辛醚通过调控长链非编码RNA MALAT1和抑制α-突触核蛋白表达来预防MPTP诱导的帕金森病。
Biomed Pharmacother. 2016 Oct;83:153-159. doi: 10.1016/j.biopha.2016.06.017. Epub 2016 Jun 27.
10
Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein.EGCG 与 Cu(II) 复合物抑制 α-突触核蛋白的淀粉样聚集和 Cu(II)诱导的细胞毒性。
Molecules. 2019 Aug 14;24(16):2940. doi: 10.3390/molecules24162940.

引用本文的文献

1
Dissolvable Microneedles Embedded with Chitosan Nanoparticles for Transdermal Delivery of Pramipexole Dihydrochloride in Parkinson's Disease.用于帕金森病中盐酸普拉克索经皮递送的壳聚糖纳米颗粒包埋型可溶微针
ACS Omega. 2025 Jul 23;10(35):39923-39932. doi: 10.1021/acsomega.5c04299. eCollection 2025 Sep 9.
2
The Search for Disease Modification in Parkinson's Disease-A Review of the Literature.帕金森病疾病修饰治疗的探索——文献综述
Life (Basel). 2025 Jul 23;15(8):1169. doi: 10.3390/life15081169.
3
Pharmacological effects, molecular mechanisms and strategies to improve bioavailability of curcumin in the treatment of neurodegenerative diseases.
姜黄素在神经退行性疾病治疗中的药理作用、分子机制及提高生物利用度的策略
Front Pharmacol. 2025 Jul 10;16:1625821. doi: 10.3389/fphar.2025.1625821. eCollection 2025.
4
Neuroprotective Potential of Curcumin in Neurodegenerative Diseases: Clinical Insights Into Cellular and Molecular Signaling Pathways.姜黄素在神经退行性疾病中的神经保护潜力:细胞和分子信号通路的临床见解
J Biochem Mol Toxicol. 2025 Aug;39(8):e70369. doi: 10.1002/jbt.70369.
5
The Nasal-Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases.鼻-脑给药途径:作用机制及其在中枢神经系统疾病中的应用
MedComm (2020). 2025 Jun 6;6(6):e70213. doi: 10.1002/mco2.70213. eCollection 2025 Jun.
6
Epicoccin A Ameliorates PD-like Symptoms in Zebrafish: Enhancement of PINK1/Parkin-Dependent Mitophagy and Inhibition of Excessive Oxidative Stress.表棒曲霉素A改善斑马鱼的帕金森病样症状:增强PINK1/帕金蛋白依赖性线粒体自噬并抑制过度氧化应激
Mar Drugs. 2025 Apr 17;23(4):175. doi: 10.3390/md23040175.
7
Harnessing the Potential of Exosomes in Therapeutic Interventions for Brain Disorders.利用外泌体在脑部疾病治疗干预中的潜力。
Int J Mol Sci. 2025 Mar 11;26(6):2491. doi: 10.3390/ijms26062491.
8
Nanoodor Particles Deliver Drugs to Central Nervous System via Olfactory Pathway.纳米奥多颗粒通过嗅觉途径将药物输送到中枢神经系统。
Adv Sci (Weinh). 2025 Apr;12(15):e2408908. doi: 10.1002/advs.202408908. Epub 2025 Feb 25.
9
A nanoparticle-based wireless deep brain stimulation system that reverses Parkinson's disease.一种基于纳米颗粒的可逆转帕金森病的无线深部脑刺激系统。
Sci Adv. 2025 Jan 17;11(3):eado4927. doi: 10.1126/sciadv.ado4927. Epub 2025 Jan 15.
10
HDAC6 inhibitor-loaded brain-targeted nanocarrier-mediated neuroprotection in methamphetamine-driven Parkinson's disease.载有HDAC6抑制剂的脑靶向纳米载体介导的对甲基苯丙胺诱发帕金森病的神经保护作用
Redox Biol. 2025 Feb;79:103457. doi: 10.1016/j.redox.2024.103457. Epub 2024 Dec 5.